Correlation Between Santen Pharmaceutical and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Santen Pharmaceutical and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santen Pharmaceutical and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Santen Pharmaceutical Co and Roche Holding AG, you can compare the effects of market volatilities on Santen Pharmaceutical and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santen Pharmaceutical with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santen Pharmaceutical and Roche Holding.

Diversification Opportunities for Santen Pharmaceutical and Roche Holding

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Santen and Roche is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and Santen Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santen Pharmaceutical Co are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of Santen Pharmaceutical i.e., Santen Pharmaceutical and Roche Holding go up and down completely randomly.

Pair Corralation between Santen Pharmaceutical and Roche Holding

Assuming the 90 days horizon Santen Pharmaceutical Co is expected to generate 1.86 times more return on investment than Roche Holding. However, Santen Pharmaceutical is 1.86 times more volatile than Roche Holding AG. It trades about -0.04 of its potential returns per unit of risk. Roche Holding AG is currently generating about -0.33 per unit of risk. If you would invest  961.00  in Santen Pharmaceutical Co on January 20, 2024 and sell it today you would lose (20.00) from holding Santen Pharmaceutical Co or give up 2.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Santen Pharmaceutical Co  vs.  Roche Holding AG

 Performance 
       Timeline  
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, Santen Pharmaceutical is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Roche Holding AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Santen Pharmaceutical and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Santen Pharmaceutical and Roche Holding

The main advantage of trading using opposite Santen Pharmaceutical and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santen Pharmaceutical position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind Santen Pharmaceutical Co and Roche Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal